[EN] SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS<br/>[FR] COMPOSÉS SPIROCYCLIQUES EN TANT QU'INHIBITEURS DE LA TRYPTOPHANE HYDROXYLASE
申请人:KAROS PHARMACEUTICALS INC
公开号:WO2015035113A1
公开(公告)日:2015-03-12
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
本发明涉及一种螺环化合物,它们是色氨酸羟化酶(TPH)的抑制剂,特别是异构体1(TPH1),可用于治疗与外周血清素相关的疾病或紊乱,例如胃肠道、心血管、肺部、炎症、代谢和低骨密度疾病,以及血清素综合征和癌症。